Back to Browse Journals » Patient Related Outcome Measures » Volume 3

Impact of controlling atrial fibrillation on outcomes relevant to the patient: focus on dronedarone

Authors Chahal CAA, Ali O, Hunter RJ, Schilling RJ

Published Date December 2012 Volume 2012:3 Pages 95—103


Received 19 December 2011, Accepted 12 November 2012, Published 19 December 2012

C Anwar A Chahal, Omer Ali, Ross J Hunter, Richard J Schilling

Department of Cardiology Research, St Bartholomew's Hospital, London, United Kingdom

Abstract: Atrial fibrillation (AF) is a substantial cause of mortality and morbidity in the Western world. It is a massive burden on health care systems, and its prevalence is expected to double over the next 20 years. Trials evaluating antiarrhythmic drugs or catheter ablation have focused on recurrence of arrhythmia, perhaps neglecting outcomes relevant to patients, such as symptoms, need for antiarrhythmic drugs, need for hospitalization, and rates of stroke and death. An association has been demonstrated between sinus rhythm and survival in several studies, and there is evidence emerging that successful catheter ablation may reduce rates of stroke and death. Similarly, dronedarone has been shown to reduce hospitalizations and death in patients with paroxysmal AF or persistent AF of recent onset, although it may cause adverse events in permanent AF. New antiarrhythmic drugs are a welcome addition to the armamentarium, since there are limitations to current antiarrhythmic drugs. In particular, sotalol, flecainide, and propafenone cannot be used safely in those with structural heart disease, and amiodarone has important adverse reactions that limit long-term use. Indeed, the use of conventional antiarrhythmic drugs may negate any survival benefit derived from maintaining sinus rhythm. Although dronedarone appears promising with respect to hard endpoints such as stroke and death in certain patients, it may not be safe for those with heart failure or those with permanent AF. Furthermore, the trials suggesting that dronedarone may impact on these endpoints were compared with placebo rather than with an active comparator group. Further "head-to-head" comparisons between dronedarone and other antiarrhythmic drugs are needed to determine whether this property is unique to dronedarone alone.

Keywords: atrial fibrillation, rhythm, antiarrhythmics, ablation, stroke, dronedarone

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

Dissociation in schizophrenia and borderline personality disorder

Pec O, Bob P, Raboch J

Neuropsychiatric Disease and Treatment 2014, 10:487-491

Published Date: 17 March 2014

Perioperative hyperglycemia is associated with postoperative neurocognitive disorders after cardiac surgery

Zhang X, Yan X, Gorman J, Hoffman SN, Zhang L, Boscarino JA

Neuropsychiatric Disease and Treatment 2014, 10:361-370

Published Date: 19 February 2014

Diagnostic performance of a combination of Mini-Mental State Examination and Clock Drawing Test in detecting Alzheimer’s disease

Kato Y, Narumoto J, Matsuoka T, Okamura A, Koumi H, Kishikawa Y, Terashima S, Fukui K

Neuropsychiatric Disease and Treatment 2013, 9:581-586

Published Date: 30 April 2013

Dabigatran for prophylaxis of thromboembolic events in patients with atrial fibrillation

Ehrlich JR, Hammwöhner M, Goette A

Research Reports in Clinical Cardiology 2012, 3:11-21

Published Date: 18 January 2012

Self-assessed health of young-to-middle-aged adults in an English-speaking Caribbean nation

Paul A Bourne, Neva South-Bourne

Patient Related Outcome Measures 2010, 1:127-140

Published Date: 28 September 2010

Temporal variation of out-of-hospital cardiac arrests in an equatorial climate

Marcus EH Ong, Faith SP Ng, Susan Yap, et al

Open Access Emergency Medicine 2010, 2:37-43

Published Date: 15 April 2010

Potential misinterpretations caused by collapsing upper categories of comorbidity indices: An illustration from a cohort of older breast cancer survivors

Thomas P Ahern, Jaclyn LF Bosco, Rebecca A Silliman, Marianne Ulcickas Yood, et al.

Clinical Epidemiology 2009, 1:93-100

Published Date: 23 June 2009